{"id":"NCT05386030","sponsor":"Croma-Pharma GmbH","briefTitle":"Saypha® VOLUME Lidocaine for Midface Augmentation","officialTitle":"A Randomized, Subject- and Evaluator-blinded, Controlled, Non-inferiority Multicenter, Parallel Group Comparison Study to Evaluate Effectiveness and Safety of Saypha® VOLUME Lidocaine for Midface Augmentation to Correct Volume Deficit","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2022-08-16","primaryCompletion":"2023-10-04","completion":"2024-12-11","firstPosted":"2022-05-23","resultsPosted":"2025-01-16","lastUpdate":"2025-01-16"},"enrollment":562,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Moderate to Severe Midface Volume Deficit"],"interventions":[{"type":"COMBINATION_PRODUCT","name":"saypha® VOLUME Lidocaine","otherNames":[]},{"type":"COMBINATION_PRODUCT","name":"Juvéderm® Voluma™ XC","otherNames":[]}],"arms":[{"label":"saypha® VOLUME Lidocaine","type":"EXPERIMENTAL"},{"label":"Juvéderm® Voluma™ XC","type":"ACTIVE_COMPARATOR"}],"summary":"The clinical investigation is a randomized, subject- and evaluator-blinded, active treatment controlled, multicenter, clinical investigation, to demonstrate the non inferiority of saypha® VOLUME Lidocaine to one of the devices approved for the same indication (Juvéderm® Voluma™ XC).","primaryOutcome":{"measure":"The Percentage of Responders on the 5-point Mid-Face Volume Deficit Severity Scale (MVDSS) at Week 24 - Per Protocol Dataset","timeFrame":"Week 24","effectByArm":[{"arm":"Saypha® VOLUME Lidocaine","deltaMin":268,"sd":null},{"arm":"Juvéderm® Voluma™ XC","deltaMin":124,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"}]},"eligibility":{"minAge":"22 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":16,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":4,"n":322},"commonTop":["Headache","COVID-19","Palpatory finding abnormal","Nasopharyngitis","Injection site bruising"]}}